Kathryn Beal on Aftercare for Patients with Primary Brain Tumors

Video

Kathryn Beal discusses what aftercare looks like for patients with primary brain tumors who have recieved a combination of radiation treatment and chemotherapy.

Kathryn Beal, MD, of Memorial Sloan Kettering Cancer Center, discusses aftercare for patients who have undergone combination therapy for primary brain tumors.

Side effects from radiation therapy can include fatigue, neurological symptoms, and edema. When radiation is combined with immunotherapy treatments, the standard radiation side effects can be exacerbated. There are also side effects that are unique to immunotherapy

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
2 experts are featured in this series.
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Related Content
Image of a row of vials lined up on a counter

VXM01 Vaccine/Avelumab Displays Safety, Early Clinical Activity in GBM

Ashling Wahner
April 8th 2025
Article

VXM01 plus avelumab was tolerable and could potentially produce clinically meaningful responses in patients with recurrent glioblastoma.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

FDA on blue background

Virus Therapy Gets Orphan Drug Designation for Glioma Treatment

Ryan Scott
November 10th 2024
Article

The FDA granted an orphan drug designation to herpes simplex virus type 1 (HSV-1) oncolytic virus MB-108 for malignant glioma treatment.

FDA Approves Ion Torrent Oncomine Dx Target for Brain Cancer

FDA Approves Ion Torrent Oncomine Dx Target for Brain Cancer

Caroline Seymour
October 21st 2024
Article

The FDA approved a companion diagnostic for vorasidenib for patients with grade 2 astrocytoma or oligodendroglioma.

drawing of a brain on yellow background

MTX110 May Improve Survival in Glioblastoma

Russ Conroy
October 21st 2024
Article

An investigational formula of panobinostat called MTX110 may improve outcomes in patients with recurrent glioblastoma.

brain with a tumor in it

MR-Linac Reduced Radiation to Healthy Brain Tissue in Glioma

Russ Conroy
October 12th 2024
Article

Weekly MR-Linac adaptive radiotherapy limited exposure to normal brain tissue in patients with high-grade glioma.